HEADER TRANSFERASE/TRANSFERASE INHIBITOR 12-JUN-12 4FK3
TITLE B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX3203
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: PROTO-ONCOGENE B-RAF, P94, V-RAF MURINE SARCOMA VIRAL
COMPND 5 ONCOGENE HOMOLOG B1;
COMPND 6 EC: 2.7.11.1;
COMPND 7 ENGINEERED: YES;
COMPND 8 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: BRAF, BRAF1, RAFB1;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING, ONCOGENIC
KEYWDS 2 V600E, KINASE-KINASE INHIBITOR COMPLEX, TRANSFERASE-TRANSFERASE
KEYWDS 3 INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR Y.ZHANG,W.WANG,K.Y.J.ZHANG
REVDAT 2 28-FEB-24 4FK3 1 REMARK SEQADV
REVDAT 1 08-AUG-12 4FK3 0
SPRSDE 08-AUG-12 4FK3 3C4D
JRNL AUTH J.TSAI,J.T LEE,W.WANG,J.ZHANG,H.CHO,S.MAMO,R.BREMER,
JRNL AUTH 2 S.GILLETTE,J.KONG,N.K.HAASS
JRNL TITL DISCOVERY OF A SELECTIVE INHIBITOR OF ONCOGENIC B-RAF KINASE
JRNL TITL 2 WITH POTENT ANTIMELANOMA ACTIVITY.
JRNL REF PROC.NATL.ACAD.SCI.USA V. 105 3041 2008
JRNL REFN ISSN 0027-8424
JRNL PMID 18287029
REMARK 2
REMARK 2 RESOLUTION. 2.65 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7.3_928)
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : ML
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 55.24
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4
REMARK 3 NUMBER OF REFLECTIONS : 17913
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.262
REMARK 3 R VALUE (WORKING SET) : 0.259
REMARK 3 FREE R VALUE : 0.315
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.090
REMARK 3 FREE R VALUE TEST SET COUNT : 912
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 55.2485 - 5.0683 1.00 2582 130 0.2295 0.2871
REMARK 3 2 5.0683 - 4.0232 1.00 2472 126 0.2232 0.2480
REMARK 3 3 4.0232 - 3.5148 1.00 2456 116 0.2497 0.3300
REMARK 3 4 3.5148 - 3.1934 1.00 2375 132 0.2743 0.3195
REMARK 3 5 3.1934 - 2.9646 0.99 2404 139 0.2969 0.3486
REMARK 3 6 2.9646 - 2.7898 0.99 2366 125 0.3340 0.4084
REMARK 3 7 2.7898 - 2.6501 0.99 2346 144 0.3399 0.4057
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.00
REMARK 3 SHRINKAGE RADIUS : 0.73
REMARK 3 K_SOL : 0.34
REMARK 3 B_SOL : 39.08
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.490
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.730
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 13.06460
REMARK 3 B22 (A**2) : -3.00930
REMARK 3 B33 (A**2) : -10.05530
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.004 4175
REMARK 3 ANGLE : 0.816 5627
REMARK 3 CHIRALITY : 0.059 609
REMARK 3 PLANARITY : 0.004 717
REMARK 3 DIHEDRAL : 19.346 1577
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 3
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: (CHAIN A AND (RESID 448:718 OR RESID 901:920 ) )
REMARK 3 ORIGIN FOR THE GROUP (A): 1.2343 40.0405 19.5212
REMARK 3 T TENSOR
REMARK 3 T11: 0.3841 T22: 0.1989
REMARK 3 T33: 0.2075 T12: -0.0097
REMARK 3 T13: 0.0686 T23: -0.0246
REMARK 3 L TENSOR
REMARK 3 L11: 1.0951 L22: 6.8156
REMARK 3 L33: 3.5882 L12: -0.4297
REMARK 3 L13: 0.3183 L23: -3.4019
REMARK 3 S TENSOR
REMARK 3 S11: 0.2552 S12: -0.0867 S13: -0.0734
REMARK 3 S21: -0.9970 S22: -0.2089 S23: -0.1071
REMARK 3 S31: 0.7796 S32: -0.0833 S33: -0.0464
REMARK 3 TLS GROUP : 2
REMARK 3 SELECTION: (CHAIN A AND RESID 921:921 ) OR (CHAIN B AND (RESID
REMARK 3 448:721 OR RESID 801:808 ) )
REMARK 3 ORIGIN FOR THE GROUP (A): -1.2086 61.1917 -5.9268
REMARK 3 T TENSOR
REMARK 3 T11: 0.4247 T22: 0.3534
REMARK 3 T33: 0.2017 T12: -0.0415
REMARK 3 T13: 0.1537 T23: -0.0470
REMARK 3 L TENSOR
REMARK 3 L11: 4.0063 L22: 5.2709
REMARK 3 L33: 5.8509 L12: -2.9458
REMARK 3 L13: 3.2672 L23: -3.8116
REMARK 3 S TENSOR
REMARK 3 S11: 0.4318 S12: 0.5927 S13: 0.1918
REMARK 3 S21: -1.0708 S22: -0.5264 S23: -0.1658
REMARK 3 S31: 1.3927 S32: 0.1142 S33: 0.0844
REMARK 3 TLS GROUP : 3
REMARK 3 SELECTION: (CHAIN A AND RESID 801:801 )
REMARK 3 ORIGIN FOR THE GROUP (A): -1.5258 50.1464 20.1820
REMARK 3 T TENSOR
REMARK 3 T11: 0.8637 T22: 0.3474
REMARK 3 T33: 0.3639 T12: -0.0819
REMARK 3 T13: 0.1403 T23: -0.0238
REMARK 3 L TENSOR
REMARK 3 L11: 8.0761 L22: 6.7001
REMARK 3 L33: 6.9775 L12: -3.4414
REMARK 3 L13: -1.3651 L23: 3.3399
REMARK 3 S TENSOR
REMARK 3 S11: -0.4800 S12: -0.1687 S13: -0.7581
REMARK 3 S21: 0.1941 S22: -0.2995 S23: 0.5073
REMARK 3 S31: 0.2943 S32: -0.4619 S33: 0.5828
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 4FK3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JUN-12.
REMARK 100 THE DEPOSITION ID IS D_1000072997.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 29-MAR-05
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 6.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ALS
REMARK 200 BEAMLINE : 8.3.1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.1
REMARK 200 MONOCHROMATOR : M
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM
REMARK 200 DATA SCALING SOFTWARE : SCALA
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17913
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650
REMARK 200 RESOLUTION RANGE LOW (A) : 76.263
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4
REMARK 200 DATA REDUNDANCY : NULL
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.72
REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHENIX
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 45.05
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM BISTRIS AT PH 6.0, 12.5% 2,5
REMARK 280 -HEXANEDIOL, AND 12% PEG3350, VAPOR DIFFUSION, SITTING DROP,
REMARK 280 TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.60250
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.23650
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.70450
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.23650
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.60250
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.70450
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2, 3
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 3
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 432
REMARK 465 LYS A 433
REMARK 465 LYS A 434
REMARK 465 GLY A 435
REMARK 465 HIS A 436
REMARK 465 HIS A 437
REMARK 465 HIS A 438
REMARK 465 HIS A 439
REMARK 465 HIS A 440
REMARK 465 HIS A 441
REMARK 465 GLY A 442
REMARK 465 SER A 443
REMARK 465 ARG A 444
REMARK 465 ASP A 445
REMARK 465 SER A 446
REMARK 465 SER A 447
REMARK 465 LEU A 597
REMARK 465 ALA A 598
REMARK 465 THR A 599
REMARK 465 GLU A 600
REMARK 465 LYS A 601
REMARK 465 SER A 602
REMARK 465 ARG A 603
REMARK 465 TRP A 604
REMARK 465 SER A 605
REMARK 465 GLY A 606
REMARK 465 SER A 607
REMARK 465 HIS A 608
REMARK 465 GLN A 609
REMARK 465 PHE A 610
REMARK 465 GLU A 611
REMARK 465 GLN A 612
REMARK 465 LEU A 613
REMARK 465 GLN A 628
REMARK 465 ASP A 629
REMARK 465 SER A 630
REMARK 465 ARG A 719
REMARK 465 GLU A 720
REMARK 465 LEU A 721
REMARK 465 SER A 722
REMARK 465 GLY A 723
REMARK 465 MET B 432
REMARK 465 LYS B 433
REMARK 465 LYS B 434
REMARK 465 GLY B 435
REMARK 465 HIS B 436
REMARK 465 HIS B 437
REMARK 465 HIS B 438
REMARK 465 HIS B 439
REMARK 465 HIS B 440
REMARK 465 HIS B 441
REMARK 465 GLY B 442
REMARK 465 SER B 443
REMARK 465 ARG B 444
REMARK 465 ASP B 445
REMARK 465 SER B 446
REMARK 465 SER B 447
REMARK 465 LYS B 601
REMARK 465 SER B 602
REMARK 465 ARG B 603
REMARK 465 TRP B 604
REMARK 465 SER B 605
REMARK 465 GLY B 606
REMARK 465 SER B 607
REMARK 465 HIS B 608
REMARK 465 GLN B 609
REMARK 465 PHE B 610
REMARK 465 GLU B 611
REMARK 465 GLN B 612
REMARK 465 LEU B 613
REMARK 465 MET B 627
REMARK 465 GLN B 628
REMARK 465 ASP B 629
REMARK 465 SER B 630
REMARK 465 SER B 722
REMARK 465 GLY B 723
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 GLN A 524 157.37 130.66
REMARK 500 GLU A 545 13.28 59.46
REMARK 500 ARG A 575 -14.73 76.48
REMARK 500 ASP A 576 63.71 -158.28
REMARK 500 PRO B 492 64.59 -45.26
REMARK 500 THR B 521 -35.32 -132.95
REMARK 500 PRO B 523 -110.33 -107.38
REMARK 500 ARG B 575 -1.50 65.22
REMARK 500 ASP B 576 49.97 -151.63
REMARK 500 ASP B 587 -5.54 77.75
REMARK 500 ASN B 588 20.51 -158.32
REMARK 500 PHE B 595 -72.64 -56.33
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 325 A 801
DBREF 4FK3 A 444 723 UNP P15056 BRAF_HUMAN 443 722
DBREF 4FK3 B 444 723 UNP P15056 BRAF_HUMAN 443 722
SEQADV 4FK3 MET A 432 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 LYS A 433 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 LYS A 434 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 GLY A 435 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 HIS A 436 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 HIS A 437 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 HIS A 438 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 HIS A 439 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 HIS A 440 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 HIS A 441 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 GLY A 442 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 SER A 443 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 ALA A 543 UNP P15056 ILE 542 ENGINEERED MUTATION
SEQADV 4FK3 SER A 544 UNP P15056 ILE 543 ENGINEERED MUTATION
SEQADV 4FK3 LYS A 551 UNP P15056 ILE 550 ENGINEERED MUTATION
SEQADV 4FK3 ARG A 562 UNP P15056 GLN 561 ENGINEERED MUTATION
SEQADV 4FK3 ASN A 588 UNP P15056 LEU 587 ENGINEERED MUTATION
SEQADV 4FK3 GLU A 600 UNP P15056 VAL 599 ENGINEERED MUTATION
SEQADV 4FK3 SER A 630 UNP P15056 LYS 629 ENGINEERED MUTATION
SEQADV 4FK3 GLU A 667 UNP P15056 PHE 666 ENGINEERED MUTATION
SEQADV 4FK3 SER A 673 UNP P15056 TYR 672 ENGINEERED MUTATION
SEQADV 4FK3 ARG A 688 UNP P15056 ALA 687 ENGINEERED MUTATION
SEQADV 4FK3 SER A 706 UNP P15056 LEU 705 ENGINEERED MUTATION
SEQADV 4FK3 ARG A 709 UNP P15056 GLN 708 ENGINEERED MUTATION
SEQADV 4FK3 GLU A 713 UNP P15056 SER 712 ENGINEERED MUTATION
SEQADV 4FK3 GLU A 716 UNP P15056 LEU 715 ENGINEERED MUTATION
SEQADV 4FK3 GLU A 720 UNP P15056 SER 719 ENGINEERED MUTATION
SEQADV 4FK3 SER A 722 UNP P15056 PRO 721 ENGINEERED MUTATION
SEQADV 4FK3 GLY A 723 UNP P15056 LYS 722 ENGINEERED MUTATION
SEQADV 4FK3 MET B 432 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 LYS B 433 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 LYS B 434 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 GLY B 435 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 HIS B 436 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 HIS B 437 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 HIS B 438 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 HIS B 439 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 HIS B 440 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 HIS B 441 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 GLY B 442 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 SER B 443 UNP P15056 EXPRESSION TAG
SEQADV 4FK3 ALA B 543 UNP P15056 ILE 542 ENGINEERED MUTATION
SEQADV 4FK3 SER B 544 UNP P15056 ILE 543 ENGINEERED MUTATION
SEQADV 4FK3 LYS B 551 UNP P15056 ILE 550 ENGINEERED MUTATION
SEQADV 4FK3 ARG B 562 UNP P15056 GLN 561 ENGINEERED MUTATION
SEQADV 4FK3 ASN B 588 UNP P15056 LEU 587 ENGINEERED MUTATION
SEQADV 4FK3 GLU B 600 UNP P15056 VAL 599 ENGINEERED MUTATION
SEQADV 4FK3 SER B 630 UNP P15056 LYS 629 ENGINEERED MUTATION
SEQADV 4FK3 GLU B 667 UNP P15056 PHE 666 ENGINEERED MUTATION
SEQADV 4FK3 SER B 673 UNP P15056 TYR 672 ENGINEERED MUTATION
SEQADV 4FK3 ARG B 688 UNP P15056 ALA 687 ENGINEERED MUTATION
SEQADV 4FK3 SER B 706 UNP P15056 LEU 705 ENGINEERED MUTATION
SEQADV 4FK3 ARG B 709 UNP P15056 GLN 708 ENGINEERED MUTATION
SEQADV 4FK3 GLU B 713 UNP P15056 SER 712 ENGINEERED MUTATION
SEQADV 4FK3 GLU B 716 UNP P15056 LEU 715 ENGINEERED MUTATION
SEQADV 4FK3 GLU B 720 UNP P15056 SER 719 ENGINEERED MUTATION
SEQADV 4FK3 SER B 722 UNP P15056 PRO 721 ENGINEERED MUTATION
SEQADV 4FK3 GLY B 723 UNP P15056 LYS 722 ENGINEERED MUTATION
SEQRES 1 A 292 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER ARG
SEQRES 2 A 292 ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE
SEQRES 3 A 292 THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE GLY THR
SEQRES 4 A 292 VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS
SEQRES 5 A 292 MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN LEU GLN
SEQRES 6 A 292 ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS THR ARG
SEQRES 7 A 292 HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER THR LYS
SEQRES 8 A 292 PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU GLY SER
SEQRES 9 A 292 SER LEU TYR HIS HIS LEU HIS ALA SER GLU THR LYS PHE
SEQRES 10 A 292 GLU MET LYS LYS LEU ILE ASP ILE ALA ARG GLN THR ALA
SEQRES 11 A 292 ARG GLY MET ASP TYR LEU HIS ALA LYS SER ILE ILE HIS
SEQRES 12 A 292 ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS GLU ASP
SEQRES 13 A 292 ASN THR VAL LYS ILE GLY ASP PHE GLY LEU ALA THR GLU
SEQRES 14 A 292 LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU GLN LEU
SEQRES 15 A 292 SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL ILE ARG
SEQRES 16 A 292 MET GLN ASP SER ASN PRO TYR SER PHE GLN SER ASP VAL
SEQRES 17 A 292 TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET THR GLY
SEQRES 18 A 292 GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP GLN ILE
SEQRES 19 A 292 ILE GLU MET VAL GLY ARG GLY SER LEU SER PRO ASP LEU
SEQRES 20 A 292 SER LYS VAL ARG SER ASN CYS PRO LYS ARG MET LYS ARG
SEQRES 21 A 292 LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG
SEQRES 22 A 292 PRO SER PHE PRO ARG ILE LEU ALA GLU ILE GLU GLU LEU
SEQRES 23 A 292 ALA ARG GLU LEU SER GLY
SEQRES 1 B 292 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER ARG
SEQRES 2 B 292 ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE
SEQRES 3 B 292 THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE GLY THR
SEQRES 4 B 292 VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS
SEQRES 5 B 292 MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN LEU GLN
SEQRES 6 B 292 ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS THR ARG
SEQRES 7 B 292 HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER THR LYS
SEQRES 8 B 292 PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU GLY SER
SEQRES 9 B 292 SER LEU TYR HIS HIS LEU HIS ALA SER GLU THR LYS PHE
SEQRES 10 B 292 GLU MET LYS LYS LEU ILE ASP ILE ALA ARG GLN THR ALA
SEQRES 11 B 292 ARG GLY MET ASP TYR LEU HIS ALA LYS SER ILE ILE HIS
SEQRES 12 B 292 ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS GLU ASP
SEQRES 13 B 292 ASN THR VAL LYS ILE GLY ASP PHE GLY LEU ALA THR GLU
SEQRES 14 B 292 LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU GLN LEU
SEQRES 15 B 292 SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL ILE ARG
SEQRES 16 B 292 MET GLN ASP SER ASN PRO TYR SER PHE GLN SER ASP VAL
SEQRES 17 B 292 TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET THR GLY
SEQRES 18 B 292 GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP GLN ILE
SEQRES 19 B 292 ILE GLU MET VAL GLY ARG GLY SER LEU SER PRO ASP LEU
SEQRES 20 B 292 SER LYS VAL ARG SER ASN CYS PRO LYS ARG MET LYS ARG
SEQRES 21 B 292 LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG
SEQRES 22 B 292 PRO SER PHE PRO ARG ILE LEU ALA GLU ILE GLU GLU LEU
SEQRES 23 B 292 ALA ARG GLU LEU SER GLY
HET 325 A 801 31
HETNAM 325 N-{2,4-DIFLUORO-3-[(5-PYRIDIN-3-YL-1H-PYRROLO[2,3-
HETNAM 2 325 B]PYRIDIN-3-YL)CARBONYL]PHENYL}ETHANESULFONAMIDE
HETSYN 325 PLX3203
FORMUL 3 325 C21 H16 F2 N4 O3 S
FORMUL 4 HOH *29(H2 O)
HELIX 1 1 THR A 491 ARG A 506 1 16
HELIX 2 2 SER A 536 ALA A 543 1 8
HELIX 3 3 GLU A 549 LYS A 570 1 22
HELIX 4 4 GLU A 586 ASN A 588 5 3
HELIX 5 5 SER A 616 MET A 620 5 5
HELIX 6 6 ALA A 621 ARG A 626 1 6
HELIX 7 7 SER A 634 GLY A 652 1 19
HELIX 8 8 ASN A 661 ARG A 671 1 11
HELIX 9 9 ASP A 677 VAL A 681 5 5
HELIX 10 10 PRO A 686 LEU A 697 1 12
HELIX 11 11 LYS A 700 ARG A 704 5 5
HELIX 12 12 SER A 706 GLU A 716 1 11
HELIX 13 13 GLN B 493 ARG B 506 1 14
HELIX 14 14 SER B 536 HIS B 542 1 7
HELIX 15 15 GLU B 549 LYS B 570 1 22
HELIX 16 16 GLU B 586 ASN B 588 5 3
HELIX 17 17 ALA B 621 ARG B 626 1 6
HELIX 18 18 SER B 634 GLY B 652 1 19
HELIX 19 19 ASN B 661 GLY B 672 1 12
HELIX 20 20 PRO B 686 LEU B 697 1 12
HELIX 21 21 LYS B 700 ARG B 704 5 5
HELIX 22 22 SER B 706 LEU B 721 1 16
SHEET 1 A 5 THR A 458 SER A 465 0
SHEET 2 A 5 THR A 470 LYS A 475 -1 O VAL A 471 N ILE A 463
SHEET 3 A 5 ASP A 479 MET A 484 -1 O VAL A 480 N GLY A 474
SHEET 4 A 5 ALA A 526 GLN A 530 -1 O ILE A 527 N LYS A 483
SHEET 5 A 5 PHE A 516 SER A 520 -1 N GLY A 518 O VAL A 528
SHEET 1 B 2 ILE A 582 HIS A 585 0
SHEET 2 B 2 THR A 589 ILE A 592 -1 O THR A 589 N HIS A 585
SHEET 1 C 5 THR B 458 GLY B 464 0
SHEET 2 C 5 THR B 470 LYS B 475 -1 O VAL B 471 N GLY B 464
SHEET 3 C 5 ASP B 479 MET B 484 -1 O MET B 484 N THR B 470
SHEET 4 C 5 ALA B 526 GLN B 530 -1 O THR B 529 N ALA B 481
SHEET 5 C 5 PHE B 516 SER B 520 -1 N GLY B 518 O VAL B 528
SHEET 1 D 2 ILE B 582 HIS B 585 0
SHEET 2 D 2 THR B 589 ILE B 592 -1 O LYS B 591 N PHE B 583
SITE 1 AC1 12 VAL A 471 ALA A 481 LYS A 483 LEU A 514
SITE 2 AC1 12 THR A 529 GLN A 530 TRP A 531 CYS A 532
SITE 3 AC1 12 PHE A 583 ASP A 594 PHE A 595 GLY A 596
CRYST1 51.205 105.409 110.473 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.019529 0.000000 0.000000 0.00000
SCALE2 0.000000 0.009487 0.000000 0.00000
SCALE3 0.000000 0.000000 0.009052 0.00000